SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011876
Filing Date
2021-05-17
Accepted
2021-05-17 16:28:34
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 829858
2 ex31-1.htm EX-31.1 17260
3 ex31-2.htm EX-31.2 17338
4 ex32-1.htm EX-32.1 9536
  Complete submission text file 0001493152-21-011876.txt   3900129

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ghsi-20210331.xml EX-101.INS 576988
6 XBRL SCHEMA FILE ghsi-20210331.xsd EX-101.SCH 42687
7 XBRL CALCULATION FILE ghsi-20210331_cal.xml EX-101.CAL 51225
8 XBRL DEFINITION FILE ghsi-20210331_def.xml EX-101.DEF 177933
9 XBRL LABEL FILE ghsi-20210331_lab.xml EX-101.LAB 320959
10 XBRL PRESENTATION FILE ghsi-20210331_pre.xml EX-101.PRE 262199
Mailing Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128 858-605-9055
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 21931242
SIC: 2834 Pharmaceutical Preparations